BusinessI-MED Pharma’s I-PEN® Receives Regulatory Approval from INVIMA in Colombia and ANMAT in ArgentinaBy Nasdaq OMXApr 3, 2018, 6:30 PM UTC
BusinessI-MED Pharma's I-PEN® Does Not Infringe the TearLab PatentBy Nasdaq OMXFeb 20, 2018, 8:44 PM UTC
BusinessI-PEN®, I-DROP® and I-PLUG® now available in Spain and Portugal through Partnership with IMEXBy Nasdaq OMXJan 8, 2018, 2:16 PM UTC
BusinessI-PEN®, I-DROP® and I-LID’N LASH® will be available in Denmark, Sweden and NorwayBy Nasdaq OMXOct 6, 2017, 7:17 PM UTC
